Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
暂无分享,去创建一个
[1] Bernard Chevalier,et al. First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study , 2012, Circulation. Cardiovascular interventions.
[2] Patrick W Serruys,et al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? , 2012, European heart journal.
[3] A. Curcio,et al. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[4] C. Indolfi,et al. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). , 2005, The American journal of cardiology.